113 related articles for article (PubMed ID: 10209207)
1. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner.
Bradley AJ; Brooks DE; Norris-Jones R; Devine DV
Biochim Biophys Acta; 1999 Apr; 1418(1):19-30. PubMed ID: 10209207
[TBL] [Abstract][Full Text] [Related]
2. Unusual electrostatic effects on binding of C1q to anionic liposomes: role of anionic phospholipid domains and their line tension.
Bradley AJ; Maurer-Spurej E; Brooks DE; Devine DV
Biochemistry; 1999 Jun; 38(25):8112-23. PubMed ID: 10387057
[TBL] [Abstract][Full Text] [Related]
3. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
Jiang H; Robey FA; Gewurz H
J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
[TBL] [Abstract][Full Text] [Related]
4. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
Tan LA; Yang AC; Kishore U; Sim RB
Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
[TBL] [Abstract][Full Text] [Related]
5. Complement activation by phospholipids: the interplay of factor H and C1q.
Tan LA; Yu B; Sim FC; Kishore U; Sim RB
Protein Cell; 2010 Nov; 1(11):1033-49. PubMed ID: 21153520
[TBL] [Abstract][Full Text] [Related]
6. Liposome-induced activation of the classical complement pathway does not require immunoglobulin.
Marjan J; Xie Z; Devine DV
Biochim Biophys Acta; 1994 Jun; 1192(1):35-44. PubMed ID: 8204648
[TBL] [Abstract][Full Text] [Related]
7. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
[TBL] [Abstract][Full Text] [Related]
8. DNA binds and activates complement via residues 14-26 of the human C1q A chain.
Jiang H; Cooper B; Robey FA; Gewurz H
J Biol Chem; 1992 Dec; 267(35):25597-601. PubMed ID: 1460055
[TBL] [Abstract][Full Text] [Related]
9. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.
Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ
Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300
[TBL] [Abstract][Full Text] [Related]
10. Impact of the surface charge of polydiacetylene micelles on their interaction with human innate immune protein C1q and the complement system.
Thielens NM; Belime A; Gravel E; Ancelet S; Caneiro C; Doris E; Ling WL
Int J Pharm; 2018 Jan; 536(1):434-439. PubMed ID: 29208412
[TBL] [Abstract][Full Text] [Related]
11. Binding of complement component C1q by spectrin.
Comis A; Easterbrook-Smith SB
Biochim Biophys Acta; 1986 Apr; 870(3):426-31. PubMed ID: 3486005
[TBL] [Abstract][Full Text] [Related]
12. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster S; Bonnell B; Rogers J
Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
[TBL] [Abstract][Full Text] [Related]
13. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
14. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
Jiang HX; Siegel JN; Gewurz H
J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
[TBL] [Abstract][Full Text] [Related]
15. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.
Roumenina LT; Kantardjiev AA; Atanasov BP; Waters P; Gadjeva M; Reid KB; Mantovani A; Kishore U; Kojouharova MS
Biochemistry; 2005 Nov; 44(43):14097-109. PubMed ID: 16245926
[TBL] [Abstract][Full Text] [Related]
16. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
17. Interaction of linear cationic peptides with phospholipid membranes and polymers of sialic acid.
Kuznetsov AS; Dubovskii PV; Vorontsova OV; Feofanov AV; Efremov RG
Biochemistry (Mosc); 2014 May; 79(5):459-68. PubMed ID: 24954597
[TBL] [Abstract][Full Text] [Related]
18. Interaction between complement subcomponent C1q and bacterial lipopolysaccharides.
Zohair A; Chesne S; Wade RH; Colomb MG
Biochem J; 1989 Feb; 257(3):865-73. PubMed ID: 2649081
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide.
Roumenina LT; Popov KT; Bureeva SV; Kojouharova M; Gadjeva M; Rabheru S; Thakrar R; Kaplun A; Kishore U
Biochim Biophys Acta; 2008 Sep; 1784(9):1271-6. PubMed ID: 18513495
[TBL] [Abstract][Full Text] [Related]
20. A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway.
Kishore U; Strong P; Perdikoulis MV; Reid KB
J Immunol; 2001 Jan; 166(1):559-65. PubMed ID: 11123337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
